October 21, 2011
Jefferson City, Mo.— Attorney General Koster today announced Missouri has reached a settlement with Pfizer, Inc., a major pharmaceutical manufacturer headquartered in New York. The multi-state settlement ends a government investigation into allegations that the company engaged in illegal off-label marketing schemes to promote the sales of its urology drug Detrol for uses that were not approved by the Food and Drug Administration (FDA). The settlement will return $102,000 to Missouri’s Medicaid program. Medicaid is a state-administered healthcare program for the indigent and disabled funded jointly by the states and the federal government.
Detrol was FDA-approved in March 1998 for the treatment of overactive bladder with symptoms of urinary incontinence, urgency, and frequency. The settlement resolves allegations that Pfizer designed promotional activities aimed at increasing Detrol prescriptions for men for non-FDA-approved uses.
“One of my top priorities as Attorney General is to enforce our laws against those who take advantage of Missouri taxpayers by committing Medicaid fraud,” Koster said. “This settlement is a significant amount of money to be returned to taxpayers and should serve as notice to pharmaceutical companies that the Attorney General’s Medicaid Fraud Unit will continue to hold them accountable.”
Koster said citizens should report suspected Medicaid provider fraud or abuse and neglect to his Medicaid Fraud Hotline toll free at 800-286-3932; e-mail the complaint to email@example.com; or complete a complaint form at the Attorney General’s Medicaid Fraud Website at http://ago.mo.gov/divisions/medicaid-fraud-control-unit-faqs.htm.